Inmune Bio Executives Increase Holdings Through Direct Offering
| Reporter Name | Relationship | Type | Amount | SEC Filing |
|---|---|---|---|---|
| Moss David J | Chief Financial Officer, 10% Owner | Purchase | $49,023 | Form 4 |
| Tesi Raymond Joseph | President and CEO, 10% Owner | Purchase | $98,047 | Form 4 |
David J Moss, the Chief Financial Officer and a 10% Owner of Inmune Bio, has expanded his stake in the company by purchasing 7,690 shares of Common Stock on September 12, 2024, at a price of $6.375 per share, resulting in a total investment of $49,023. Following this transaction, Moss's direct ownership in Inmune Bio has increased to 1,275,869 shares.
Raymond Joseph Tesi, the President, CEO, and a 10% owner of Inmune Bio, also participated in the direct offering, acquiring 15,380 shares of common stock on the same date at $6.375 per share, with a total purchase amount of $98,047. This purchase raises Tesi's direct holdings in the company to 1,554,106 shares. Both executives' acquisitions were part of a registered direct offering priced at $6.50 per share, with an aggregate purchase price of $13,000,000.